ARCT - Arcturus Therapeutics Holdings Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
9,349
9,349
-203,674
-72,148
-25,991
Depreciation & amortization
1,527
1,527
1,193
882
684
Stock based compensation
30,611
30,611
28,915
6,764
1,982
Change in working capital
-12,557
-12,557
31,233
21,216
15,982
Accounts receivable
603
603
-1,242
54
2,302
Accounts Payable
-3,112
-3,112
-769
4,812
3,155
Other working capital
24,267
24,267
-138,449
-44,603
-7,263
Other non-cash items
2,173
2,173
8,382
162
873
Net cash provided by operating activites
31,993
31,993
-135,043
-42,861
-6,445
Cash flows from investing activities
Investments in property, plant and equipment
-7,726
-7,726
-3,406
-1,742
-818
Purchases of investments
-
-
-
0
-
Sales/Maturities of investments
-
-
-
0
-
Net cash used for investing activites
-7,726
-7,726
-3,406
-1,742
-818
Cash flows from financing activities
Debt repayment
-5,000
-5,000
-
-
-
Common stock issued
411
411
515
423,819
36,823
Net cash used privided by (used for) financing activities
-2,859
-2,859
48,016
436,145
41,907
Net change in cash
21,408
21,408
-90,433
391,542
34,644
Cash at beginning of period
372,569
372,569
463,002
71,460
36,816
Cash at end of period
393,977
393,977
372,569
463,002
71,460
Free Cash Flow
Operating Cash Flow
31,993
31,993
-135,043
-42,861
-6,445
Capital Expenditure
-7,726
-7,726
-3,406
-1,742
-818
Free Cash Flow
24,267
24,267
-138,449
-44,603
-7,263